DNTHDianthus Therapeutics, Inc.
$82.35+124% 1Y
$82.35
$32.9252 weeks$115.67
Is the price fair?
What DNTH's price assumes
Dianthus Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 2459× revenue.
2459
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 10.2
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 2260
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 10.2
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 2260
- Market capitalisation
- $5.01B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks